WellMedr Review: One $99 Page, Sold Three Times

The one-sentence version

WellMedr publishes a real price before it asks for your medical history, names the pharmacy that fills your prescription and the clinical group that writes it, and puts the consultation inside the figure it quotes — four things most of the providers here manage two of. Then it sells its entire longevity line from one page it produced three times by find-and-replace, and bills the "monthly" price it publishes every 21 days. It grades B, 9 points out of 14. The grade is computed from published terms alone and cannot see who pays us — WellMedr is a paid partner here.

What it is, and who is behind it

The operator is Wellmedr LLC. Clinical care is delivered by OpenLoop Healthcare Partners, PC and its affiliated state professional corporations — the telehealth consent names them individually — and fulfillment is by Mycelium Pharmacy. Both are named on surfaces WellMedr controls, which is more than most of this ranking manages, and the pharmacy detail matters more than it sounds: a compounded medicine is only as good as the facility that made it, and a company willing to put a name to that is a company you can go and check.

The catch is where it is named. "Mycelium Pharmacy" appears in the privacy policy and nowhere a buyer would look. It is not on the home page, not on the pricing page, not in the FAQ, and not on any of the three product pages this review is about.

The longevity line ranked here is three compounded injectables at $99 a month each: NAD+, vitamin B12, and sermorelin. Alongside it sits a much larger compounded GLP-1 business — semaglutide and tirzepatide, brand Ozempic and Zepbound, and an eight-product "microdose" line — and that is what this site's link actually opens. More on that below, because it is a thing you should know before you click.

There is no published list of served states. Its FAQ answers the question with "We are expanding rapidly — eligibility is checked during sign-up."

The finding: three products, one page

Set the sermorelin page beside the B12 page and normalize the product name, and they are word for word identical — the same 295 lines, the same headings, the same FAQ, the same fine print. Both are the NAD+ page with a molecule's name substituted in. The NAD+ page differs from them only in its title and one embedded video.

The substitution did not stop at the headings. What both pages actually print:

> "Sermorelin (Nicotinamide Adenine Dinucleotide) therapy has shown potential to support energy metabolism, cognitive performance, and cellular repair."

> "Safety Information: B12 is a naturally occurring coenzyme essential for mitochondrial function, DNA repair, and healthy aging."

Nicotinamide adenine dinucleotide is NAD+. It is not sermorelin, which is a 29-amino-acid analog of growth-hormone-releasing hormone, and it is not B12, which is cobalamin. Neither of those molecules is a coenzyme essential for mitochondrial function and DNA repair; that sentence describes the third product on the shelf.

And the doses came along with the chemistry. All three pages offer "500mg and 1000mg injection options". For NAD+ those are ordinary figures. Sermorelin and B12 are dosed in micrograms — so on two of the three pages the stated dose is off by roughly a thousandfold. Nobody is going to be dispensed a gram of sermorelin; a licensed prescriber sets the real dose after the intake. That is precisely the point. The numbers on the page are not describing the product being sold, and a reader has no way to tell which of the other statements on it are.

We are not calling this deceptive, and there is no sign it is. It reads exactly like what it appears to be: one landing page duplicated twice, with the molecule's name swapped and nobody reading the result. But this is a longevity ranking, and the whole proposition of a compounded peptide program is that somebody competent is paying attention to the molecule. A page that calls sermorelin a coenzyme and prices it by the milligram is evidence about the attention, not about the medicine.

What it costs, and the 21 days

Every figure below was read on WellMedr's own pages on 10 August 2026.

NAD+, vitamin B12, sermorelin — each "Starting at $99/month", each with "Same price every dose — no hidden fees, no surprise charges", and each stating that "The price includes your online medical consultation, prescription, and free shipping." Beside them: "No Hidden Fees · No Monthly Membership · Cancel Anytime", and a "Get Up To $150 Off Today!" banner, which is a discount rather than a price.

Taken at face value that is a good structure, and it earns real credit below. One figure, no membership, no term, the visit inside it.

Then read the refund policy. Verbatim:

> "By completing your purchase, you are enrolling in a recurring subscription program. Your subscription will automatically renew every 21 days to ensure continuity of care and medication delivery."

Twenty-one days is not a month. It is 17.4 charges a year rather than 12. At $99 a charge that is about $1,721 a year, not $1,188 — roughly 45% more than the published monthly figure implies, on a bill that renews indefinitely.

And the site gives the period four different answers depending on which page you open. Its GLP-1 plan cards say "shipped every 4 weeks" (13 charges a year). Its sitewide banner sells "12/month Plans". Its refund policy says every 21 days. Its Terms of Use §6 says renewals run in "monthly, 3-month, or 6-month cycles depending on your plan". We cannot tell you which one governs your card, and neither can the site.

This is why price transparency scores 2 of 4 rather than 4. The rubric's middle rung is for exactly this: a figure that is published — you have a number to start from and to hold them to — and then contradicted by the seller's own documents. It is better than publishing nothing, worse than a figure that binds.

One more thing about the refund policy, since you are already there. It gives the cancellation notice window as 48 hours in one paragraph and 72 hours in two others; it promises refunds if your medication has not yet been ordered in one section and states that "once a purchase is completed and your medical intake has been approved... your order becomes final and non-refundable" in another; it still contains unfilled template placeholders — "[insert email]", "[Wellmedr LLC]" — and one sentence breaks off mid-word. It is three policies stacked on one page, and they do not agree.

Where our link sends you, and why we are telling you

This is a disclosure rather than a criticism of WellMedr, because it is a limitation on our side.

The affiliate offer behind this row exposes no landing-page selector. Every link from this site resolves to wellmedr.com/pages/get-started-weight-loss — the GLP-1 weight-loss pricing page — not to the NAD+ or sermorelin page this review is about. Where other partners here let us pin a longevity lander, this one does not, and inventing a selector is worse than useless: an invalid one falls back silently.

So if you click through, expect to land on a page selling compounded semaglutide at "$59 a month" and tirzepatide at "$99 a month", and navigate from there. Two warnings about that page while you are on it. Its $59 figure is not a month-to-month rate — the sitewide banner ties it to a twelve-month plan ("Lock In $200 OFF Every Month, or $59/mo on 12/month Plans — For Life") — and its $99 is a different product from the $99 on the sermorelin page that happens to share a number.

Clinical oversight, the pharmacy, and the FDA answer

Oversight: two points, earned. No consultation fee appears anywhere in the published structure. The longevity pages state the medical consultation, the prescription and shipping are inside the $99, and there is no membership stacked on top. That is what this factor asks for and WellMedr answers it plainly.

Pharmacy: one point of two. Our one test is where a claim is published, applied identically to every row. WellMedr names its dispensing pharmacy — Mycelium Pharmacy, in its privacy policy, a surface it controls — which is the middle rung. It does not publish a 503A or 503B claim anywhere; what it says is "FDA-registered compounding facilities", and registration with the FDA is a different fact from compounding to a stated standard. We do not credit one as the other, here or on any other row.

Human support: zero, and it is close. What the longevity pages state as inside the $99 is the consultation, the prescription and shipping. "1:1 Medical Support" appears as a badge, and the sitewide bar advertises "Unlimited provider messaging" — but the explicit "Unlimited Messaging With Licensed Clinicians · Included" block sits on the GLP-1 pricing page and is about that program. Ongoing clinical support published as part of the price of the line we are grading is what this factor asks for, and it is not there. Pallas Health scores zero here on the same reasoning.

Longevity line: four of four. Three compounded longevity injectables sold at a published price is exactly what this site ranks, whatever the quality of the copy describing them. The factor asks what is on the shelf.

And then there is the FDA answer. WellMedr's FAQ asks "Are these medications FDA approved?" and answers:

> "Yes. We only work with U.S. licensed pharmacies that dispense FDA-approved medications."

The footer of that same page says the opposite:

> "Compounded medications offered through Wellmedr. are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality."

The footer is right. Compounded drugs are not FDA-approved, and the agency does not verify their safety, effectiveness or quality before they are marketed¹. The longevity pages carry the correct version too — "These statements have not been evaluated by the Food and Drug Administration" — so the "Yes" is one answer out of step with the rest of the site rather than the site's position. It is still the answer sitting in the FAQ, on the page a buyer with exactly that question will open, and the microdose page says it a second time.

Clean on regulatory record. We screened FDA's live warning-letter index on 10 August 2026 for "wellmedr", "Wellmedr LLC", "mycelium", "Mycelium Pharmacy", "openloop" and "OpenLoop Health" — zero records each, in a pass where a known-lettered company came back positive, so the clean result is a real one and not a broken query. The pharmacy was screened as well as the brand, which is only possible because WellMedr named it.

Not credited: the LegitScript badge. WellMedr displays a "LegitScript Certified" badge on its pricing page, but it carries no seal number and links to a keyword search rather than to a certificate. The lookup sits behind a bot challenge that returned the identical response for a genuinely certified merchant and for a domain we invented, so it cannot tell the two apart and neither can we. We neither credit the claim nor dispute it.

The verdict

B, 9 of 14. Four points for a genuine longevity line, two for putting the consultation inside a published price, two of four for a figure its own refund policy contradicts, one of two for naming a pharmacy without stating a compounding standard, and zero for support it does not publish as included.

Buy from WellMedr if the structure is what you want — one figure, no membership, no term, the visit included — and you are willing to establish two things first: what your billing period actually is, in writing, before you enter a card; and what dose you are being prescribed, in the units the medicine is actually measured in. On the second one, do not take the page's word for it. It is not describing your product.

Compounded NAD+, B12 and sermorelin are not FDA-approved for anti-aging, and the lifespan evidence for any of them is unproven — see our evidence review. That is true of most of this category and it is the most important sentence on this page.